Overview
Cronos Group Inc. is a globally recognized cannabis company headquartered in Toronto, Canada. Operating primarily in the burgeoning legal cannabis industry, Cronos Group dedicates itself to cultivating and manufacturing innovative cannabinoid products. Its portfolio includes both recreational and medical marijuana products, distributed across an international market spanning North America, including Canada and the United States, as well as several other countries through strategic partnerships and subsidiaries. A significant aspect of their operations focuses on researching advanced cannabinoid technologies, aiming to enhance and diversify product offerings. Key projects include developing lab-grown cannabis and expanding product lines in CBD-infused wellness and beauty sectors. Through these ventures, Cronos Group seeks to capitalize on the growing acceptance and legalization of cannabis worldwide.
Basic Stats
The share price of Cronos Group Inc. as of September 4, 2025 is $2.50 / share. This is a decrease of -3.85% from the prior week. The market cap (or net worth) of Cronos Group Inc. as of September 4, 2025 is $959.52 MM.
The Factor Analysis chart (below right) shows a view of Cronos Group Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 959.52 MM |
| EV | 211.10 MM |
| Shares Out. | 383.81 MM |
| Earnings Date | |
| EPS (TTM) | 0.05 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 1.40 |
| Short Shares Avail. | 8.40 MM |
| Short Interest | 2.77 MM |
| Short Float | 1.37 % |
| Days to Cover | 0.78 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | 13.93 % |
| Volatility (1 yr) | 0.44 |
| Beta | 0.40 |
| Sharpe Ratio (1 yr) | 0.22 |
| Sortino Ratio (1 yr) | 0.49 |
| PE Ratio | 51.79 |
| Price/Book | 0.85 |
| Price/TBV | 0.95 |
| Book/Market | 1.18 |
| EBIT/EV | 0.09 |
| EBIT(3yr avg)/EV | -0.25 |
| ROA | 0.02 |
| ROE | 0.02 |
| ROIC | 0.02 |
| CROIC | -0.05 |
| OCROIC | 0.02 |
| Implied Volatility | 82.21 % |
| Put/Call OI Ratio | 0.32 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Cronos Group Inc. is $1.77. The forecasts range from a low of $1.75 to a high of $1.82. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Cronos Group Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-11-09 | ROTH MKM | Buy | Buy | Maintains |
| 2023-11-08 | CIBC CAPITAL MARKETS | Outperform | Outperform | Maintains |
| 2023-08-08 | CIBC CAPITAL MARKETS | Outperform | Outperform | Maintains |
| 2023-08-07 | CIBC CAPITAL MARKETS | Outperform | Outperform | Maintains |
| 2023-07-06 | ROTH MKM | Buy | Buy | Maintains |
| 2023-07-06 | STIFEL NICOLAUS AND COMPANY, INCORPORATED | Hold | Hold | Maintains |
| 2023-07-05 | ROTH MKM | Buy | Buy | Maintains |
| 2023-07-05 | STIFEL NICOLAUS AND COMPANY, INCORPORATED | Hold | Hold | Maintains |
| 2023-05-18 | ROTH MKM | Buy | Buy | Maintains |
| 2023-05-17 | ROTH MKM | Buy | Buy | Maintains |
| 2023-05-09 | STIFEL NICOLAUS AND COMPANY, INCORPORATED | Hold | Hold | Maintains |
| 2023-05-09 | RAYMOND JAMES LTD. | Outperform | Outperform | Maintains |
| 2023-05-09 | CIBC CAPITAL MARKETS | Neutral | Outperform | Upgrade |
| 2023-05-08 | STIFEL NICOLAUS AND COMPANY, INCORPORATED | Hold | Hold | Maintains |
| 2023-05-08 | RAYMOND JAMES LTD. | Outperform | Outperform | Maintains |
| 2023-05-08 | CIBC CAPITAL MARKETS | Neutral | Outperform | Upgrade |
| 2023-03-28 | ROTH MKM | Buy | Buy | Maintains |
| 2023-03-06 | STIFEL NICOLAUS AND COMPANY, INCORPORATED | Hold | Hold | Maintains |
| 2023-03-01 | RAYMOND JAMES LTD. | Outperform | Outperform | Maintains |
| 2023-02-28 | CIBC CAPITAL MARKETS | Neutral | Outperform | Upgrade |
| 2022-11-08 | MKM PARTNERS | Buy | Buy | Maintains |
| 2022-11-07 | MKM PARTNERS | Buy | Buy | Maintains |
| 2022-08-15 | STA Research | Buy | Maintains | |
| 2022-08-09 | PI FINANCIAL CORP | Neutral | Neutral | Maintains |
| 2022-08-08 | PI FINANCIAL CORP | Neutral | Neutral | Maintains |
| 2022-07-30 | Raymond James Capital | Buy | Reiterate | |
| 2022-05-13 | Bank of America Securities | Sell | Initiate | |
| 2022-05-11 | Morningstar | Buy | Maintains | |
| 2022-05-10 | CIBC CAPITAL MARKETS | Neutral | Neutral | Maintains |
| 2022-05-09 | CIBC CAPITAL MARKETS | Neutral | Neutral | Maintains |
| 2022-03-22 | STA Research | Buy | Initiate | |
| 2022-03-22 | Barclays | Underweight | Maintains | |
| 2022-03-07 | Piper Sandler | Hold | Initiate | |
| 2022-03-06 | PIPER SANDLER COMPANIES | Neutral | Neutral | Maintains |
| 2022-03-05 | PIPER SANDLER COMPANIES | Neutral | Neutral | Maintains |
| 2022-03-02 | MKM Partners | Buy | Initiate | |
| 2022-03-02 | Raymond James Capital | Outperform | Initiate | |
| 2022-03-02 | Morningstar | Buy | Maintains | |
| 2022-02-22 | Canaccord Capital | Sell | Initiate | |
| 2021-11-23 | Barclays | Underweight | Initiate | |
| 2021-06-15 | Raymond James Financial | Outperform | Initiate | |
| 2021-06-07 | Raymond James Financial | Outperform | Reiterate | |
| 2021-03-01 | Cowen | 8 | 14 | Upgrade |
| 2020-11-16 | Jefferies | 5.6 | 5 | Downgrade |
| 2020-08-10 | Jefferies | 6 | 5.6 | Downgrade |
| 2020-05-12 | Jefferies | 7 | 6 | Downgrade |
| 2020-05-11 | Stifel Nicolaus | 8 | 7.5 | Downgrade |
| 2020-04-14 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2020-04-07 | Cowen | 10 | 8 | Downgrade |
| 2020-04-01 | PI Financial | Buy | Neutral | Downgrade |
| 2020-03-31 | Canaccord Genuity | Hold | Sell | Downgrade |
| 2020-03-03 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2020-02-21 | PI Financial | Buy | Initiate | |
| 2020-01-02 | Jefferies | 10 | 7 | Downgrade |
| 2019-12-20 | Raymond James Financial | Outperform | Initiate | |
| 2019-11-13 | Canaccord Genuity | 13 | 12 | Downgrade |
| 2019-11-13 | CIBC World Markets | 20 | 17 | Downgrade |
| 2019-11-13 | Bank of America | Buy | Maintains | |
| 2019-10-22 | Piper Jaffray | Overweight | Maintains | |
| 2019-10-11 | Jefferies | 15 | 10 | Downgrade |
| 2019-10-04 | CIBC World Markets | 25 | 20 | Downgrade |
| 2019-09-05 | BMO Capital Markets | Underperform | Market Perform | Upgrade |
| 2019-09-03 | Cowen | 21 | 17 | Downgrade |
| 2019-08-13 | Piper Jaffray | Overweight | Initiate | |
| 2019-08-09 | Canaccord Genuity | Sell | Hold | Upgrade |
| 2019-06-28 | Consumer Edge | Equal-Weight | Initiate | |
| 2019-06-06 | Stifel Nicolaus | Hold | Initiate | |
| 2019-06-05 | Bank of America | Underperform | Buy | Upgrade |
| 2019-05-03 | Jefferies | 17 | 15 | Downgrade |
| 2019-04-17 | Bank of America | Underperform | Initiate | |
| 2019-03-28 | Cormark Securities | 17 | 25 | Upgrade |
| 2019-03-27 | Canaccord Genuity | Hold | Sell | Downgrade |
| 2019-03-26 | PI Financial | Buy | Neutral | Downgrade |
| 2019-03-11 | BMO Capital | Market Perform | Underperform | Downgrade |
| 2019-03-07 | Eight Capital | Buy | Neutral | Downgrade |
| 2019-03-05 | Cowen | Market Perform | Initiate | |
| 2019-03-05 | Cowen & Co. | Market Perform | Initiate | |
| 2019-02-25 | Jefferies | Underperform | Initiate | |
| 2019-02-05 | GMP Securities | Buy | Hold | Downgrade |
| 2019-01-18 | CIBC World Markets | Outperform | Initiate | |
| 2019-01-18 | CIBC | Outperform | Initiate | |
| 2018-12-10 | Cormark Securities | 10 | 17 | Upgrade |
| 2018-12-10 | GMP Securities | 14 | 24 | Upgrade |
| 2018-12-10 | Canaccord Genuity | 9 | 17 | Upgrade |
| 2018-11-15 | Canaccord Genuity | 7.5 | 9 | Upgrade |
| 2018-08-15 | Canaccord Genuity | Sell | Hold | Upgrade |
| 2024-08-07 | ROTH MKM | Buy | Buy | Maintains |
| 2024-05-13 | CIBC CAPITAL MARKETS | Outperform | Outperform | Maintains |
| 2023-11-08 | ROTH MKM | Buy | Buy | Maintains |
| 2023-11-07 | CIBC CAPITAL MARKETS | Outperform | Outperform | Maintains |
| 2024-12-12 | CONSUMER EDGE RESEARCH | Equalweight | Equalweight | Maintains |
| 2024-11-14 | CANACCORD GENUITY | Buy | Buy | Maintains |
| 2024-11-12 | ROTH MKM | Buy | Buy | Maintains |
| 2025-03-02 | CONSUMER EDGE RESEARCH | Equalweight | Equalweight | Maintains |
| 2025-02-28 | CANACCORD GENUITY | Buy | Buy | Maintains |
| 2025-02-27 | ROTH CAPITAL PARTNERS | Buy | Buy | Maintains |
| 2025-05-07 | ROTH CAPITAL PARTNERS | Buy | Buy | Maintains |
| 2025-05-07 | CANACCORD GENUITY | Buy | Buy | Maintains |
